Al-Dawaa Medical Services Future Growth
Future criteria checks 3/6
Al-Dawaa Medical Services is forecast to grow earnings and revenue by 14% and 6.7% per annum respectively. EPS is expected to grow by 12.1% per annum. Return on equity is forecast to be 30.4% in 3 years.
Key information
14.0%
Earnings growth rate
12.1%
EPS growth rate
| Consumer Retailing earnings growth | 19.1% |
| Revenue growth rate | 6.7% |
| Future return on equity | 30.4% |
| Analyst coverage | Good |
| Last updated | 12 Nov 2024 |
Recent future growth updates
Recent updates
Al-Dawaa Medical Services Company (TADAWUL:4163) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 14
Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price
Sep 24The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing
Jul 29Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)
Jun 03Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality
May 08Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns
Apr 05Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger
Dec 26Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25
Sep 03Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing
Jul 13Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 22Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)
Apr 10Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio
Mar 14Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?
Dec 08Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 7,097 | 506 | 514 | 826 | 5 |
| 12/31/2025 | 6,659 | 444 | 436 | 754 | 6 |
| 12/31/2024 | 6,287 | 373 | 539 | 782 | 2 |
| 9/30/2024 | 6,187 | 359 | 405 | 666 | N/A |
| 6/30/2024 | 6,000 | 355 | 474 | 703 | N/A |
| 3/31/2024 | 5,850 | 348 | 597 | 836 | N/A |
| 12/31/2023 | 5,741 | 329 | 502 | 726 | N/A |
| 9/30/2023 | 5,742 | 326 | 704 | 848 | N/A |
| 6/30/2023 | 5,612 | 303 | 716 | 881 | N/A |
| 3/31/2023 | 5,485 | 295 | 529 | 743 | N/A |
| 12/31/2022 | 5,372 | 305 | 528 | 778 | N/A |
| 9/30/2022 | 5,212 | 285 | 266 | 651 | N/A |
| 6/30/2022 | 5,163 | 275 | 142 | 519 | N/A |
| 3/31/2022 | 5,119 | 247 | 217 | 561 | N/A |
| 12/31/2021 | 5,034 | 239 | 361 | 670 | N/A |
| 9/30/2021 | 4,977 | 254 | 413 | 649 | N/A |
| 6/30/2021 | 4,958 | 300 | 400 | 644 | N/A |
| 3/31/2021 | 4,932 | 286 | 348 | 566 | N/A |
| 12/31/2020 | 4,962 | 246 | 166 | 378 | N/A |
| 12/31/2019 | 3,962 | 233 | 356 | 515 | N/A |
| 12/31/2018 | 3,797 | 228 | 244 | 392 | N/A |
| 12/31/2017 | 3,376 | 121 | N/A | 568 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4163's forecast earnings growth (14% per year) is below the savings rate (14.7%).
Earnings vs Market: 4163's earnings (14% per year) are forecast to grow faster than the SA market (6.7% per year).
High Growth Earnings: 4163's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4163's revenue (6.7% per year) is forecast to grow faster than the SA market (-0.1% per year).
High Growth Revenue: 4163's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4163's Return on Equity is forecast to be high in 3 years time (30.4%)